With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
Anthony McDonnell, Senior Policy Analyst, Center for Global Development
Adrian La Porta, Technical Director, Bryden Wood
Melissa Malhame, Vice President, Global Business Development, PharmaJet
Prashant Yadav, Senior Fellow, Center for Global Development and Professor, Technology and Operations Management, INSEAD
Tom Johnston, Senior Consultant, Coalition for Epidemic Preparedness Innovations
Kalipso Chalkidou, Director of Global Health Policy, Center for Global Development and Professor of Practice in Global Health at Imperial College London.
ABOUT THE EVENT
Much of the discussion around society’s ability to return to “normality” after the COVID-19 pandemic has centered on the development of a vaccine. This has led to unprecedented collaboration and investment.
In early October, we released a report looking at possible timelines for when vaccines are likely to be ready for approval and hosted an event that looked at the challenges of finding a vaccine and optimizing the portfolio. However, finding a vaccine for COVID is only the first step in inoculating people. Whichever candidate or candidates are found will need to be manufactured at an unprecedented scale so that the vaccine can be distributed to people across the world.
To help answer questions about the portfolio, and how long it will take to find and manufacture new vaccines, we are launching an online web tool that will allow users to input their assumption of the characteristics of a vaccine that will be effective into our model.
In this event, organized as part of a collaboration with Ariadne Labs, we will launch our web tool, showing users how to use it. We will then discuss the challenges to manufacturing COVID-19 vaccines at scales, our modelling results, and their implications.
If you have questions for our panelists, please submit them to email@example.com, tweet @CGDev #CGDTalks, or submit your comments via YouTube.